21 U.S.C. § 134 to 135b
Repealed. Pub. L. 107–171, title X, § 10418(a)(17), (18), May 13, 2002, 116 Stat. 508
Repealed. Pub. L. 107–171, title X, § 10418(a)(17), (18), May 13, 2002, 116 Stat. 508
Search
Search by citation or keyword across the current edition within Title 21.
Repealed. Pub. L. 107–171, title X, § 10418(a)(17), (18), May 13, 2002, 116 Stat. 508
Repealed. Pub. L. 107–171, title X, § 10418(a)(17), (18), May 13, 2002, 116 Stat. 508
Introduction into, or sale in, State or Territory or District of Columbia of dairy or food products falsely labeled or branded
Introduction into, or sale in, State or Territory or District of Columbia of dairy or food products falsely labeled or branded
Penalty for sale or introduction of falsely labeled dairy or food products; venue
Penalty for sale or introduction of falsely labeled dairy or food products; venue
FDA rare neurodegenerative disease grant program
FDA rare neurodegenerative disease grant program
Collection of fees for inspection services
Collection of fees for inspection services
Priority review to encourage treatments for tropical diseases
Priority review to encourage treatments for tropical diseases
Recommendations for investigations of drugs for rare diseases or conditions
Recommendations for investigations of drugs for rare diseases or conditions
Grants and contracts for development of drugs for rare diseases and conditions
Grants and contracts for development of drugs for rare diseases and conditions
Priority review to encourage treatments for rare pediatric diseases
Priority review to encourage treatments for rare pediatric diseases
Priority review to encourage treatments for agents that present national security threats
Priority review to encourage treatments for agents that present national security threats